1. Home
  2. IMMR vs MDXH Comparison

IMMR vs MDXH Comparison

Compare IMMR & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.10

Market Cap

216.7M

Sector

Technology

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.30

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
MDXH
Founded
1993
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Computer peripheral equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
216.7M
183.4M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
IMMR
MDXH
Price
$6.10
$3.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$12.25
$7.67
AVG Volume (30 Days)
316.3K
107.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
2.12
N/A
Revenue
$35,013,000.00
N/A
Revenue This Year
$168.87
$23.34
Revenue Next Year
$109.72
$22.98
P/E Ratio
$2.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.65
$1.35
52 Week High
$8.15
$5.33

Technical Indicators

Market Signals
Indicator
IMMR
MDXH
Relative Strength Index (RSI) 43.71 41.09
Support Level $5.71 $3.05
Resistance Level $7.03 $3.78
Average True Range (ATR) 0.21 0.18
MACD 0.01 -0.02
Stochastic Oscillator 56.88 13.21

Price Performance

Historical Comparison
IMMR
MDXH

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: